Pulmonary vein reconduction is common in patients undergoing re-ablation after first-time pulsed field ablation for atrial fibrillation

1 September 2025 (08:45 - 08:55)

Organised by:

Abstract

Sign in to view the resources

Slides

About the speaker

Doctor Christina Alhede

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)

4 More presentations in this session

Presentation thumbnail

LVA ablation following the PVI strategy showed better outcomes in diabetic patients with wide LVA compared to narrow LVA: A Sub-Analysis of the SUPPRESS-AF Trial

Doctor T. Ozaki (Osaka, JP)

Abstract Slides

Presentation thumbnail

Plasma histidine as biomarker for recurrent atrial fibrillation after catheter ablation

Doctor H. Xu (Beijing, CN)

Abstract Slides

Presentation thumbnail

Balancing stroke and bleeding risks: the impact of stopping anticoagulation after aAF ablation - a systematic review and meta-analysis

Doctor S. Koolaji (Stevenage, GB)

Abstract Slides

Presentation thumbnail

Left atrial appendage isolation in catheter ablation of atrial fibrillation: an updated systematic review and meta-analysis.

Doctor M. Nassar (Tanta, EG)

Abstract Slides

Access the full session

Session thumbnail

New insights in catheter ablation of atrial fibrillation

The Event

Event poster

ESC Congress 2025

1 September 2025 08:45 CET

You may be interested in

Congress Presentation

Pulmonary vein isolation durability across energy modalities: redo insights from a high-volume center

Congress Presentation

Safety and impact of pulsed field ablation on pulmonary vein stenosis after prior thermal ablation

Congress Presentation

Efficacy of high-power short-duration radiofrequency ablation in arrhythmia burden-driven redo pulmonary vein isolation: a prospective study

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources